Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • james hadfield
    Moderator
    Cambridge, UK
    Community Forum
    • Feb 2008
    • 224

    #1

    Run statistics on GA2 or GA2x...

    Hi everyone,
    I have thought for a while that it would be incredibly useful to get some idea of how other peoples instruments are performing compared to mine. It would certainly give me some possibilities when something looks suspicious with a run. There is always the possibility of spotting issues more quickl with a reagent as well, failures might crop up all over the place at the same time. This idea comes from an Affymetrix database that was setup in my last institute to compare Affy rpt QC files. I was also reinspired by the Sanger plots; http://www.sanger.ac.uk/Teams/Team117/#mpsa_error.

    To do this I would like to see some run metrics brought together in one place in a format that would be easily downloadable and comparable. Wherever they are brought together it would be best if anyone could upload files of run data easily. The easier it is to get data into a site the more useable the database becomes and it becomes self perpetuating.

    Posible metrics would include some of the summary stats; yield, cpt, %PF, error, etc. Alongside this we would need to see run length, run type, instrument version, library type. It might also be handy to have some data that people might consider sensitive, genome, instrument location, operator, etc. I would be happy to publish most of this from my facility and a quick question to the submitting scientist should release the rest.

    It is getting difficult to find out how well systems are perfomring when I talk to people as it is too easy to forget that we are not comparing identical runs; SE and PE, mRNA or ChIP, 35bp or 100bp, etc, etc, etc. What yield do you get from a 45bp SE run, we have had almost 6GBp which I think is good but I would like to kow if we should be trying harder!

    So how do we get started? Who will take up the chalenge and how can we decide they can be trusted to build something reliable? Would we be happy asking Illumina to do this? Will anyone else out there upload data, with or without the more sensitive metadata? Will anyone look at it?

    James.
  • Jonathan
    Member
    • Jun 2009
    • 36

    #2
    This would be most interesting -
    I have wondered quite some time now, why the machine I get my data from differs so much from specs:
    GA2 (I guess - I'm just the data-guy):
    PhiX Lane 5: 4'897'847 reads PE (so 9795694 reads in total) each 76bp long.

    To me this seems way below what is possible, doesn't it?

    Best
    -Jonathan

    Comment

    • kmcarr
      Senior Member
      • May 2008
      • 1181

      #3
      Jonathan,

      If the 4.9 million reads are PF reads then it is not unreasonably low assuming the sequencing facility is not loading a high amount of the controls. You would really need to know the number of raw clusters per lane to see if the flow cell is being utilized to its fullest. With the new pipeline 1.4 software (or SCS 2.4 with RTA) Illumina recommends loading at a concentration which will achieve 180,000-220,000 raw clusters per tile. For a GAII (100 tiles per lane) this would be 18-22 million raw clusters per lane and for the GAIIx (120 tiles per lane) the yield would be 21.6-26.4 million raw. Prior to the new software release the recommendation was for 120,000-150,000 clusters per tile. If the facility has not upped the density on their flow cells I would not be terribly disappointed to see 5 million PF clusters in a lane.

      Comment

      • der_eiskern
        Member
        • Jul 2009
        • 46

        #4
        Hi I'm interested in the metric of relating cluster density to % use-able sequences after built-in QC functions are run on the machine itself. I've heard stories of people getting great cluster density (>150,000) but only being able to map (and therefore use) 30%-50% of the reads. This type of QC might not be relevant to ChIP-seq users but resequencers and metagenomics people would like to know how efficient these machines are in practice.

        thanks for sharing your experiences,
        _der.

        Comment

        • sandyott
          Junior Member
          • Jul 2009
          • 2

          #5
          cluster density

          Has anyone ever seen a Drop in intensities mid run? we Recently upgraded to the 1.4 pipline and the scs2.4 and the new PEM with the GA2x with the large reagent bottles. most of our runs were in the 40 cycle range. we recently ran a longer one 76 cycle. at about cycle 40 we saw a huge drop in signal intensity, across both lasers and all 4 nucleotides. Our FAS is saying that the FC is overloaded (at about 220 raw clusters per tile). Saying that for longer reads RTA has issues at cycle 40.. Has anyone else heard of this? Seen anything similar?? Sounds like BS to me. But I wanted to see if anyone has seen anything similar.

          He's also suggesting lower cluster number for longer reads? I'm not sure I understand why it would matter?

          Thanks,

          Sandy

          Comment

          • tim
            Junior Member
            • Aug 2009
            • 8

            #6
            I can see why cluster density should be reduced when fragment size increases because clusters of fragments are not static but dynamic and can "sway" thus potentially interfering with neighbouring clusters. But why read length should matter, I don't know.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...